Skip to main content

Argon Inhalation for 24 Hours After Onset of Permanent Focal Cerebral Ischemia in Rats Provides Neuroprotection and Improves Neurologic Outcome.

Publication ,  Journal Article
Ma, S; Chu, D; Li, L; Creed, JA; Ryang, Y-M; Sheng, H; Yang, W; Warner, DS; Turner, DA; Hoffmann, U
Published in: Crit Care Med
August 2019

OBJECTIVES: We tested the hypothesis that prolonged inhalation of 70% argon for 24 hours after in vivo permanent or temporary stroke provides neuroprotection and improves neurologic outcome and overall recovery after 7 days. DESIGN: Controlled, randomized, double-blinded laboratory study. SETTING: Animal research laboratories. SUBJECTS: Adult Wistar male rats (n = 110). INTERVENTIONS: Rats were subjected to permanent or temporary focal cerebral ischemia via middle cerebral artery occlusion, followed by inhalation of 70% argon or nitrogen in 30% oxygen for 24 hours. On postoperative day 7, a 48-point neuroscore and histologic lesion size were assessed. MEASUREMENTS AND MAIN RESULTS: After argon inhalation for 24 hours immediately following "severe permanent ischemia" induction, neurologic outcome (neuroscore, p = 0.034), overall recovery (body weight, p = 0.02), and infarct volume (total infarct volume, p = 0.0001; cortical infarct volume, p = 0.0003; subcortical infarct volume, p = 0.0001) were significantly improved. When 24-hour argon treatment was delayed for 2 hours after permanent stroke induction or until after postischemic reperfusion treatment, neurologic outcomes remained significantly improved (neuroscore, p = 0.043 and p = 0.014, respectively), as was overall recovery (body weight, p = 0.015), compared with nitrogen treatment. However, infarct volume and 7-day mortality were not significantly reduced when argon treatment was delayed. CONCLUSIONS: Neurologic outcome (neuroscore), overall recovery (body weight), and infarct volumes were significantly improved after 24-hour inhalation of 70% argon administered immediately after severe permanent stroke induction. Neurologic outcome and overall recovery were also significantly improved even when argon treatment was delayed for 2 hours or until after reperfusion.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Crit Care Med

DOI

EISSN

1530-0293

Publication Date

August 2019

Volume

47

Issue

8

Start / End Page

e693 / e699

Location

United States

Related Subject Headings

  • Rats, Wistar
  • Rats
  • Random Allocation
  • Neuroprotective Agents
  • Neuroprotection
  • Male
  • Emergency & Critical Care Medicine
  • Disease Models, Animal
  • Brain Ischemia
  • Argon
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ma, S., Chu, D., Li, L., Creed, J. A., Ryang, Y.-M., Sheng, H., … Hoffmann, U. (2019). Argon Inhalation for 24 Hours After Onset of Permanent Focal Cerebral Ischemia in Rats Provides Neuroprotection and Improves Neurologic Outcome. Crit Care Med, 47(8), e693–e699. https://doi.org/10.1097/CCM.0000000000003809
Ma, Shuang, Dongmei Chu, Litao Li, Jennifer A. Creed, Yu-Mi Ryang, Huaxin Sheng, Wei Yang, David S. Warner, Dennis A. Turner, and Ulrike Hoffmann. “Argon Inhalation for 24 Hours After Onset of Permanent Focal Cerebral Ischemia in Rats Provides Neuroprotection and Improves Neurologic Outcome.Crit Care Med 47, no. 8 (August 2019): e693–99. https://doi.org/10.1097/CCM.0000000000003809.
Ma S, Chu D, Li L, Creed JA, Ryang Y-M, Sheng H, et al. Argon Inhalation for 24 Hours After Onset of Permanent Focal Cerebral Ischemia in Rats Provides Neuroprotection and Improves Neurologic Outcome. Crit Care Med. 2019 Aug;47(8):e693–9.
Ma, Shuang, et al. “Argon Inhalation for 24 Hours After Onset of Permanent Focal Cerebral Ischemia in Rats Provides Neuroprotection and Improves Neurologic Outcome.Crit Care Med, vol. 47, no. 8, Aug. 2019, pp. e693–99. Pubmed, doi:10.1097/CCM.0000000000003809.
Ma S, Chu D, Li L, Creed JA, Ryang Y-M, Sheng H, Yang W, Warner DS, Turner DA, Hoffmann U. Argon Inhalation for 24 Hours After Onset of Permanent Focal Cerebral Ischemia in Rats Provides Neuroprotection and Improves Neurologic Outcome. Crit Care Med. 2019 Aug;47(8):e693–e699.

Published In

Crit Care Med

DOI

EISSN

1530-0293

Publication Date

August 2019

Volume

47

Issue

8

Start / End Page

e693 / e699

Location

United States

Related Subject Headings

  • Rats, Wistar
  • Rats
  • Random Allocation
  • Neuroprotective Agents
  • Neuroprotection
  • Male
  • Emergency & Critical Care Medicine
  • Disease Models, Animal
  • Brain Ischemia
  • Argon